January 04, 2025 09:08 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow | Punjab cop dismissed for facilitating TV interview of Larence Bishnoi while in custody | 'Not Veer Savarkar', Congress student wing demands Delhi college be named after Manmohan Singh | 'Cowardly': PM Modi condemns New Orleans terrorist attack that killed 15 | Prashant Kishor starts fast unto death over Bihar Public Service Commission prelims cancellation demand | Bangladesh court denies bail to arrested Hindu monk Chinmoy Krishna Das
NHRC issues notice to Delhi CS, DCGI after epilepsy drug fails quality test

NHRC issues notice to Delhi CS, DCGI after epilepsy drug fails quality test

Dec 30, 2023, at 05:24 am

New Delhi/UNI: The National Human Rights Commission (NHRC) issued notices to Delhi Chief Secretary, Drugs Controller General of India (DCGI), and Police Commissioner on Friday after the epilepsy drug ‘Sodium Valproate’ reportedly failed quality testing.

Optimus submits interim result of phase III clinical trials for Molnupiravir capsules

Optimus submits interim result of phase III clinical trials for Molnupiravir capsules

Jul 21, 2021, at 10:54 pm

Hyderabad/UNI: Optimus Pharma on Wednesday said that it has submitted the interim result of phase III clinical trials for orally administered Molnupiravir capsules on patients with mild covid infection.

Madras HC issues notice to Centre on plea to declare Covishield 'unsafe'

Madras HC issues notice to Centre on plea to declare Covishield 'unsafe'

Feb 20, 2021, at 01:53 am

Chennai/IBNS: The Madras High Court has issued a notice to the Centre over a petition to declare India's indigenous coronavirus vaccine -'Covishield'- developed by Pune-based Serum Institute as "unsafe".